Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Docetaxel
Sponsor: Dartmouth-Hitchcock Medical Center
Collaborators: Hoffmann-La Roche